Dexmedetomidine Sublingual Film: A New Treatment to Reduce Agitation in Schizophrenia and Bipolar Disorders.

Danielle M KarlinLeigh Anne NelsonAustin R Campbell

Published in: The Annals of pharmacotherapy (2023)

Dexmedetomidine sublingual film provides an alternative approach to treatment of acute agitation in adults with schizophrenia and bipolar disorders based on both mechanism of action and route of administration.

Keyphrases

bipolar disorder
room temperature
acute kidney injury
drug induced
gold nanoparticles